Evidence map›Paper›PMID 40931258›Full record

Trial reportJournal of neuro-oncology2025

Physician-led versus questionnaire-based psychosocial screening in adults with high-grade glioma: a cluster-randomized controlled trial (GLIOPT).

Mirjam Renovanz, Melina Hippler, Robert Kuchen, Lorenz Doerner, David Rieger, Joachim P Steinbach, Michael W Ronellenfitsch, Martin Voss, Almuth F Kessler, Vera Nickl and 18 more

Registry-linked trialAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07409584 (Mental Health and Suicidality in Glioblastoma Patients in Germany - a Multicenter Observational Study), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07409584 recruitingnot on this mapstarted 2026, after this paper: background citation

Mental Health and Suicidality in Glioblastoma Patients in Germany - a Multicenter Observational Study (SHINE-GLIO Study)

TypeobservationalSponsorUniversity Hospital, EssenRan2026 to 2028Enrolled180ConditionsGlioblastoma (GBM)ArmsMedical history, physical examination, completing questionnaires, data collection
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Mirjam RenovanzDepartment of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany. Mirjam.renovanz@med.uni-tuebingen.de.ORCID http://orcid.org/0000-0002-2824-3720
Melina HipplerDepartment of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
Robert KuchenInstitute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-4384-7511
Lorenz DoernerDepartment of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
David RiegerDepartment of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.ORCID http://orcid.org/0009-0003-6032-4760
Joachim P SteinbachDr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-4695-2483
Michael W RonellenfitschDr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0002-1402-6290
Martin VossDr. Senckenberg Institute of Neurooncology, University Hospital Frankfurt, Frankfurt am Main, Germany.ORCID http://orcid.org/0000-0001-8469-8204
Almuth F KesslerDepartment of Neurosurgery, University Hospital Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-0605-7791
Vera NicklDepartment of Neurosurgery, University Hospital Würzburg, Würzburg, Germany.ORCID http://orcid.org/0009-0002-0453-1135
Martin MischDepartment of Neurosurgery, Charité - University Medical Center Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0001-5283-5753
Julia Sophie OnkenDepartment of Neurosurgery, Charité - University Medical Center Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-2859-4395
Marion RappDepartment of Neurosurgery, University Hospital Düsseldorf, Düsseldorf, Germany.ORCID http://orcid.org/0000-0003-2343-244X
Minou Nadji-OhlDepartment of Neurosurgery, Klinikum Stuttgart, Katharinenhospital, Stuttgart, Germany.ORCID http://orcid.org/0000-0003-1891-7389
Marcus MehlitzDepartment of Neurosurgery, Klinikum Barmherzige Brueder Trier, Trier, Germany.ORCID http://orcid.org/0000-0003-0017-9066
Jürgen MeixensbergerDepartment of Neurosurgery, University Hospital Leipzig, Leipzig, Germany.ORCID http://orcid.org/0000-0002-1385-8255
Michael Karl FehrenbachDepartment of Neurosurgery, University Hospital Leipzig, Leipzig, Germany.ORCID http://orcid.org/0000-0001-8396-7740
Naureen KericDepartment of Neurosurgery, University Medical Center Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0001-8457-0059
Florian RingelDepartment of Neurosurgery, University Medical Center Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-3132-7543
Jan CoburgerDepartment of Neurosurgery, University Hospital Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0002-3677-8258
Carolin Weiß LucasCenter for Neurosurgery, University Hospital Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0001-6463-0034
Jens WehingerDepartment of Neurology, Klinikum Ludwigsburg, Ludwigsburg, Germany.
Friederike Schmidt-GrafDepartment of Neurology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-3515-4427
Jens GemptDepartment of Neurosurgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.ORCID http://orcid.org/0000-0003-4123-4690
Marcos TatagibaCenter for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-1627-9937
Ghazaleh TabatabaiDepartment of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-3542-8782
Melanie SchranzInstitute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0003-4476-0020
Susanne SingerInstitute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.ORCID http://orcid.org/0000-0001-5784-7964

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePatients diagnosed with high-grade gliomas (HGG) often experience substantial psychosocial dis-tress. However, due to neurological and neurocognitive deficits its assessment remains challenging, and needs remain unmet. We compared a novel face-to-face assessment during doctor-patient conversations with questionnaire-based screening.

methodsIn this multicenter, two-arm cluster-randomized study involving 13 centers patients in the interven-tion group (IG) were screened for distress via physician-patient conversations, while the control group (CG) completed the Distress Thermometer. Primary outcome was the proportion of patients with poor emotional functioning (measured with the EORTC Quality of Life Questionnaire) who received specialized psychosocial care (PC) within 3 months. Data were collected via patient and physician reports and medical records. Analysis employed mixed models logistic regression.

resultsIn total, 763 patients were enrolled at baseline, and 506 completed the follow-up. The emotional functioning was poor in 302/506 (59.7%). The frequency of patients reporting PC utilization was comparable between groups (IG 93/168, 55.4% vs. CG 87/134, 64.9%, odds ratio (OR) =0.67, 95% confidence interval (CI)=0.40-1.11, p=0.115). Likewise, the provision of information about special-ized psycho-oncological care was similar (IG 112/168, 66.7% vs. CG 94/134, 70.1%, OR=0.95, 95%CI=0.39-2.29, p=0.904).

conclusionPhysician-led, face-to-face distress screening was not superior to questionnaire-based screening in facilitating psychosocial care referrals. Nonetheless, it represents a feasible and patient-centered alternative, particularly for patients with high-grade gliomas suffering from neurocognitive or func-tional deficits.

Indexed as

Brain NeoplasmsGliomaPhysician-Patient RelationsAdultAgedFemaleFollow-Up StudiesHumansMaleMiddle AgedPhysiciansQuality of LifeSurveys and QuestionnairesAssessmentDistressHigh-grade gliomaPrimary brain tumor patientsPsychosocial burdenPsychosocial careScreeningSupportive care needs

Identifiers

PMID40931258
PMCPMC12511251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.